Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/21122380http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/21122380http://www.w3.org/2000/01/rdf-schema#comment"

Objective

To investigate gene mutations of epidermal growth factor receptor (EGFR) and K-ras in Chinese patients with non-small cell lung cancer (NSCLC) and its clinicopathological significance, and to analyze the correlation between these mutations and tumor response to erlotinib treatment.

Methods

Mutations of exons 18, 19, 20 and 21 of the EGFR and codons 12, 13 of the K-ras in 301 cases of NSCLC were detected by PCR-amplification and gene sequencing. The relationship between the mutations and clinicopathological characteristics of the 301 patients was analyzed.

Results

EGFR mutations were present in 32.9% (99/301) of the samples: 3 mutation in exon 18, 59 in exon 19, 2 in exon 20, and 35 in exon 21. Mutations of K-ras were present in 4.7% (14/301) of the samples: 13 in codon 12 and 1 in codon 13. EGFR mutations were never found in tumors with K-ras mutations, suggesting a mutually exclusive relationship. EGFR mutations were more common in adenocarcinomas, non-smokers and females. Seven out of 10 erlotinib-treated patients with disease control carried EGFR mutation.

Conclusion

The frequency of EGFR mutation in Chinese NSCLC patients is higher than that in Westerners, but the frequency of K-ras mutation is quite opposite. Combined detection of EGFR gene and K-ras gene mutation may help clinicians to choose patients who may gain benefit from EGFR tyrosine kinase inhibitor (EGFR-TKI) treatment, and to predict their response to erlotinib treatment and prognosis."xsd:string
http://purl.uniprot.org/citations/21122380http://purl.uniprot.org/core/author"Guo Y."xsd:string
http://purl.uniprot.org/citations/21122380http://purl.uniprot.org/core/author"Wang M."xsd:string
http://purl.uniprot.org/citations/21122380http://purl.uniprot.org/core/author"Sun L.N."xsd:string
http://purl.uniprot.org/citations/21122380http://purl.uniprot.org/core/author"Dong N."xsd:string
http://purl.uniprot.org/citations/21122380http://purl.uniprot.org/core/author"Zhan Z.L."xsd:string
http://purl.uniprot.org/citations/21122380http://purl.uniprot.org/core/author"Sun B.C."xsd:string
http://purl.uniprot.org/citations/21122380http://purl.uniprot.org/core/author"Luan H.L."xsd:string
http://purl.uniprot.org/citations/21122380http://purl.uniprot.org/core/author"Zang F.L."xsd:string
http://purl.uniprot.org/citations/21122380http://purl.uniprot.org/core/date"2010"xsd:gYear
http://purl.uniprot.org/citations/21122380http://purl.uniprot.org/core/name"Zhonghua Zhong Liu Za Zhi"xsd:string
http://purl.uniprot.org/citations/21122380http://purl.uniprot.org/core/pages"667-670"xsd:string
http://purl.uniprot.org/citations/21122380http://purl.uniprot.org/core/title"[Relationship between EGFR and K-ras mutations and clinicopathological characteristics and response to erlotinib treatment in 301 Chinese patients with non-small cell lung cancer]."xsd:string
http://purl.uniprot.org/citations/21122380http://purl.uniprot.org/core/volume"32"xsd:string
http://purl.uniprot.org/citations/21122380http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/21122380
http://purl.uniprot.org/citations/21122380http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/21122380
http://purl.uniprot.org/uniprot/#_A0A068JD88-mappedCitation-21122380http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21122380
http://purl.uniprot.org/uniprot/#_A8K2T7-mappedCitation-21122380http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21122380
http://purl.uniprot.org/uniprot/#_A0A068JCC9-mappedCitation-21122380http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21122380
http://purl.uniprot.org/uniprot/#_A0A1Y0B9F8-mappedCitation-21122380http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21122380
http://purl.uniprot.org/uniprot/#_A0A1Y0B9F6-mappedCitation-21122380http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21122380
http://purl.uniprot.org/uniprot/#_A0A1Y0B9G5-mappedCitation-21122380http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21122380
http://purl.uniprot.org/uniprot/#_A0A1Y0B9F1-mappedCitation-21122380http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21122380
http://purl.uniprot.org/uniprot/#_A0A1Y0B9G4-mappedCitation-21122380http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21122380
▶